Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
http://www.nature.com/articles/bmt2012270.pdf
Reference21 articles.
1. Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumors. Eur J Cancer 2006; 42: 2433–2453.
2. Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L et al. American Society of Clinical Oncology. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based, clinical practice guideline. J Clin Oncol 2006; 24: 3187–3205.
3. Dingermann T . Recombinant therapeutic proteins: production platforms and challenges. Biotechnol J 2008; 3: 90–97.
4. Niederwieser D, Schmitz S . Biosimilar agents in oncology/haematology: from approval to practice. Eur J Haematol 2011; 86: 277–288.
5. Gascon P . Presently available biosimilars in hematology-oncology: G-CSF. Target Oncol 2012; 7 (Suppl 1): 29–34.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparing the effectiveness of biosimilar filgrastim (Nivestim®) versus original filgrastim (Neupogen®) for stem cell mobilization in adult and pediatric healthy donors;Journal of Oncology Pharmacy Practice;2023-06-26
2. The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donors;International Journal of Hematology;2022-04-09
3. Efficacy of three filgrastim‐intended copies for hematopoietic stem cell mobilization in healthy adult and pediatric donors in Mexico;Journal of Clinical Apheresis;2019-04-04
4. Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation;Bone Marrow Transplantation;2018-10-03
5. Medical and ethical considerations on hematopoietic stem cells mobilization for healthy donors;Transfusion Clinique et Biologique;2018-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3